1. Home
  2. VRAX vs BON Comparison

VRAX vs BON Comparison

Compare VRAX & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • BON
  • Stock Information
  • Founded
  • VRAX 2013
  • BON 2006
  • Country
  • VRAX United Kingdom
  • BON China
  • Employees
  • VRAX N/A
  • BON N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • VRAX Health Care
  • BON Health Care
  • Exchange
  • VRAX Nasdaq
  • BON Nasdaq
  • Market Cap
  • VRAX 7.3M
  • BON 6.6M
  • IPO Year
  • VRAX 2022
  • BON 2021
  • Fundamental
  • Price
  • VRAX $1.66
  • BON $1.27
  • Analyst Decision
  • VRAX
  • BON
  • Analyst Count
  • VRAX 0
  • BON 0
  • Target Price
  • VRAX N/A
  • BON N/A
  • AVG Volume (30 Days)
  • VRAX 236.4K
  • BON 35.1K
  • Earning Date
  • VRAX 02-05-2025
  • BON 02-14-2025
  • Dividend Yield
  • VRAX N/A
  • BON N/A
  • EPS Growth
  • VRAX N/A
  • BON N/A
  • EPS
  • VRAX N/A
  • BON 0.17
  • Revenue
  • VRAX $84,872.00
  • BON $23,844,556.00
  • Revenue This Year
  • VRAX $5,169.18
  • BON $223.38
  • Revenue Next Year
  • VRAX $66.97
  • BON $18.82
  • P/E Ratio
  • VRAX N/A
  • BON $7.55
  • Revenue Growth
  • VRAX 7.03
  • BON N/A
  • 52 Week Low
  • VRAX $0.60
  • BON $1.11
  • 52 Week High
  • VRAX $9.00
  • BON $5.67
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 42.25
  • BON 39.39
  • Support Level
  • VRAX $1.56
  • BON $1.11
  • Resistance Level
  • VRAX $1.86
  • BON $1.36
  • Average True Range (ATR)
  • VRAX 0.19
  • BON 0.13
  • MACD
  • VRAX -0.04
  • BON -0.01
  • Stochastic Oscillator
  • VRAX 26.31
  • BON 35.11

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products.

Share on Social Networks: